HIV-1 Protease With 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors Through Coordinated Structural Rearrangements

Biochemistry - United States
doi 10.1021/bi2018317
Full Text
Abstract

Available in full text

Categories
Biochemistry
Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Design, Synthesis, and Biological and Structural Evaluations of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2012English

Molecular Basis of HIV-1 Protease Drug Resistance: Structural Analysis of Mutant Proteases Complexed With Cyclic Urea Inhibitors

Biochemistry
Biochemistry
1997English

Anti-Hiv Drugs and Resistance: Inhibitors of HIV-1 Reverse Transcriptase and Protease

2012English

HIV Seems to Develop a Resistance to Experimental Protease Inhibitors

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Structure-Based Design of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance

English

Coevolutionary Analysis of Resistance-Evading Peptidomimetic Inhibitors of HIV-1 Protease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Developing HIV-1 Protease Inhibitors Through Stereospecific Reactions in Protein Crystals

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2016English

Predominance of Positive Epistasis Among Drug Resistance-Associated Mutations in HIV-1 Protease

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy